287 related articles for article (PubMed ID: 27582399)
1. Using Periostin as a Biomarker in the Treatment of Asthma.
Izuhara K; Ohta S; Ono J
Allergy Asthma Immunol Res; 2016 Nov; 8(6):491-8. PubMed ID: 27582399
[TBL] [Abstract][Full Text] [Related]
2. Recent developments regarding periostin in bronchial asthma.
Izuhara K; Matsumoto H; Ohta S; Ono J; Arima K; Ogawa M
Allergol Int; 2015 Sep; 64 Suppl():S3-10. PubMed ID: 26344077
[TBL] [Abstract][Full Text] [Related]
3. Periostin: An emerging biomarker for allergic diseases.
Izuhara K; Nunomura S; Nanri Y; Ono J; Takai M; Kawaguchi A
Allergy; 2019 Nov; 74(11):2116-2128. PubMed ID: 30964557
[TBL] [Abstract][Full Text] [Related]
4. Periostin in Allergic Inflammation.
Izuhara K; Arima K; Ohta S; Suzuki S; Inamitsu M; Yamamoto KI
Allergol Int; 2014; 63(2):143-151. PubMed ID: 28942959
[TBL] [Abstract][Full Text] [Related]
5. Role of serum periostin in the management of asthma and its comorbidities.
Matsumoto H
Respir Investig; 2020 May; 58(3):144-154. PubMed ID: 32205146
[TBL] [Abstract][Full Text] [Related]
6. Periostin, a novel biomarker of TH2-driven asthma.
Parulekar AD; Atik MA; Hanania NA
Curr Opin Pulm Med; 2014 Jan; 20(1):60-5. PubMed ID: 24247042
[TBL] [Abstract][Full Text] [Related]
7. Roles of Periostin in Respiratory Disorders.
Izuhara K; Conway SJ; Moore BB; Matsumoto H; Holweg CT; Matthews JG; Arron JR
Am J Respir Crit Care Med; 2016 May; 193(9):949-56. PubMed ID: 26756066
[TBL] [Abstract][Full Text] [Related]
8. Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.
Agrawal S; Townley RG
Expert Opin Biol Ther; 2014 Feb; 14(2):165-81. PubMed ID: 24283478
[TBL] [Abstract][Full Text] [Related]
9. Periostin in allergic inflammation.
Izuhara K; Arima K; Ohta S; Suzuki S; Inamitsu M; Yamamoto K
Allergol Int; 2014 Jun; 63(2):143-51. PubMed ID: 24662806
[TBL] [Abstract][Full Text] [Related]
10. Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma.
Asano T; Kanemitsu Y; Takemura M; Yokota M; Fukumitsu K; Takeda N; Ichikawa H; Uemura T; Takakuwa O; Ohkubo H; Maeno K; Ito Y; Oguri T; Maki Y; Ono J; Ohta S; Nakamura Y; Izuhara K; Suzuki M; Niimi A
Ann Am Thorac Soc; 2017 May; 14(5):667-675. PubMed ID: 28248547
[TBL] [Abstract][Full Text] [Related]
11. Roles of Periostin in Asthma.
Matsumoto H
Adv Exp Med Biol; 2019; 1132():145-159. PubMed ID: 31037633
[TBL] [Abstract][Full Text] [Related]
12. Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics.
Takahashi K; Meguro K; Kawashima H; Kashiwakuma D; Kagami SI; Ohta S; Ono J; Izuhara K; Iwamoto I
J Asthma; 2019 Mar; 56(3):236-243. PubMed ID: 29648484
[TBL] [Abstract][Full Text] [Related]
13. Lebrikizumab in the personalized management of asthma.
Thomson NC; Patel M; Smith AD
Biologics; 2012; 6():329-35. PubMed ID: 23055690
[TBL] [Abstract][Full Text] [Related]
14. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps.
Novosad J; Krčmová I; Bartoš V; Drahošová M; Vaník P; Růžičková-Kirchnerová O; Teřl M; Krejsek J
Postepy Dermatol Alergol; 2020 Apr; 37(2):240-249. PubMed ID: 32489361
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.
Hanania NA; Korenblat P; Chapman KR; Bateman ED; Kopecky P; Paggiaro P; Yokoyama A; Olsson J; Gray S; Holweg CT; Eisner M; Asare C; Fischer SK; Peng K; Putnam WS; Matthews JG
Lancet Respir Med; 2016 Oct; 4(10):781-796. PubMed ID: 27616196
[TBL] [Abstract][Full Text] [Related]
16. Periostin as a biomarker for the diagnosis of pediatric asthma.
Inoue T; Akashi K; Watanabe M; Ikeda Y; Ashizuka S; Motoki T; Suzuki R; Sagara N; Yanagida N; Sato S; Ebisawa M; Ohta S; Ono J; Izuhara K; Katsunuma T
Pediatr Allergy Immunol; 2016 Aug; 27(5):521-6. PubMed ID: 27062336
[TBL] [Abstract][Full Text] [Related]
17. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
Kanemitsu Y; Matsumoto H; Izuhara K; Tohda Y; Kita H; Horiguchi T; Kuwabara K; Tomii K; Otsuka K; Fujimura M; Ohkura N; Tomita K; Yokoyama A; Ohnishi H; Nakano Y; Oguma T; Hozawa S; Nagasaki T; Ito I; Oguma T; Inoue H; Tajiri T; Iwata T; Izuhara Y; Ono J; Ohta S; Tamari M; Hirota T; Yokoyama T; Niimi A; Mishima M
J Allergy Clin Immunol; 2013 Aug; 132(2):305-12.e3. PubMed ID: 23791506
[TBL] [Abstract][Full Text] [Related]
18. Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases.
Alzobaidi N; Rehman S; Naqvi M; Gulati K; Ray A
J Pharm Pharm Sci; 2022; 25():137-148. PubMed ID: 35379385
[TBL] [Abstract][Full Text] [Related]
19. The role of periostin in lung fibrosis and airway remodeling.
O'Dwyer DN; Moore BB
Cell Mol Life Sci; 2017 Dec; 74(23):4305-4314. PubMed ID: 28918442
[TBL] [Abstract][Full Text] [Related]
20. Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.
Tajiri T; Matsumoto H; Gon Y; Ito R; Hashimoto S; Izuhara K; Suzukawa M; Ohta K; Ono J; Ohta S; Ito I; Oguma T; Inoue H; Iwata T; Kanemitsu Y; Nagasaki T; Niimi A; Mishima M
Allergy; 2016 Oct; 71(10):1472-9. PubMed ID: 27113353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
